Neuromuscular blocking action of 2-(2-(3-pyridyl) vinyl)-3-0-tolyl-3, 4-dihydroquinazoline-4-one (SRC 909).
D000009:Abdominal Muscles; D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001001:Anura; D001285:Atropine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002415:Cats; D002794:Choline / Q000494:pharmacology; D003080:Cold Temperature; D004305:Dose-Response Relationship, Drug; D005260:Female; D005703:Gallamine Triethiodide / Q000494:pharmacology; D006018:Glycols / Q000494:pharmacology; D066298:In Vitro Techniques; D007866:Leg; D008297:Male; D008784:Methysergide / Q000494:pharmacology; D009020:Morphine / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000187:drug effects*; D009466:Neuromuscular Blocking Agents; D010425:Pentolinium Tartrate / Q000494:pharmacology; D010791:Phrenic Nerve / Q000187:drug effects; D010830:Physostigmine / Q000494:pharmacology; D011189:Potassium Chloride / Q000494:pharmacology; D011725:Pyridines / Q000494:pharmacology*; D011799:Quinazolines / Q000494:pharmacology*; D052999:Quinazolinones; D051381:Rats; D012584:Sciatic Nerve / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology; D014753:Vinyl Compounds / Q000494:pharmacology*
D006018:Glycols; D009466:Neuromuscular Blocking Agents; D011725:Pyridines; D011799:Quinazolines; D052999:Quinazolinones; D014753:Vinyl Compounds; D011189:Potassium Chloride; D009020:Morphine; D001285:Atropine; D002217:Carbachol; D010425:Pentolinium Tartrate; C005718:piriqualone; D010830:Physostigmine; D002794:Choline; D000109:Acetylcholine; D005703:Gallamine Triethiodide; D002118:Calcium; D014403:Tubocurarine; D008784:Methysergide